ArticleNature methods2025
Light-induced extracellular vesicle and particle adsorption.
Article in Nature methods, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A Scalable Bioreactor Platform for Reproducible Production and Characterization of Ovarian Cancer-Derived Extracellular Vesicles.Bioengineering (Basel, Switzerland) · 2026Article
- Review
- Article
Corrections and comments
- Update of
Authors and funding
22 authors.
Funding
Abstract
The role of extracellular vesicles (EVs) and particles (EPs/EVPs) in human health and disease has garnered considerable attention over the past two decades. However, while several types of EVPs are known to interact dynamically with the extracellular matrix and there is great potential value in producing high-fidelity EVP micropatterns, there are currently no label-free, scalable and tunable platform technologies with this capability. We introduce light-induced extracellular vesicle and particle adsorption (LEVA) as a powerful solution to study surface-bound EVPs. The versatility of LEVA is demonstrated using GFP-EV standards, EVs from conventional and bioreactor cultures, DiFi exomeres and Escherichia coli EVs, with the resulting patterns used for single-EV fluorescence imaging, cell migration on migrasome-mimetic trails and bacterial EV-mediated neutrophil swarming. LEVA will rapidly advance our understanding of extracellular matrix protein- and surface-bound EVPs and should encourage researchers from many disciplines to create new biomimetic, immunoengineering and other assays.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.